Added to YB: 2025-01-20
Pitch date: 2025-01-19
CLPT [bullish]
ClearPoint Neuro, Inc.
-20.56%
current return
Author Info
No bio for this author
Company Info
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions.
Market Cap
$438.6M
Pitch Price
$16.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-20.80
P/E
-18.67
EV/Sales
12.70
Sector
Health Care Equipment and Supplies
Category
growth
ClearPoint Neuro, Inc. - $CLPT
CLPT: FDA approval of Upstaza gene therapy delivery using ClearPoint system is game-changer. Pharma partners now drive hospital adoption. 50+ advanced hospital conversations, 100+ total. New products in 2024-2025 boost usage. Q2'23 call outlines decade strategy: pricing power, monopoly, regulatory capture. Possible $10-15M raise for breakeven.
Read full article (3 min)